Products

What will AGI do for Beclamide?

This classification denotes an anticonvulsant agent with the molecular formula C10H12ClNO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier F5N0ALI65V, chemically known as propionamide, n-benzyl-3-chloro- but generally known as beclamide, which bears US NIH Compound Identifier 10391. European Medicines Agency schedules Beclamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05675MIG. The term BECLAMIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 14, No. 1, 2000, List 43). World Health Organization schedules beclamide in its Anatomical Therapeutic Chemical (ATC) Classification. BECLAMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule beclamide under HS 29242995 and SITC 51479. As of Q4 2014, BECLAMIDE remains the US FDA Preferred Term for this commodity. Beclamide bears US NLM identifiers UMLS ID C0053067 and NCI Concept Code C75160. SMILES: C1=CC=C(C=C1)CNC(=O)CCCL.